January 25, 2018
Rose
In recent weeks, a pair of high-profile disappointments have been reported, including one just announced on a trial of the Eli Lily drug solanezumab.
from WebMD Health http://ift.tt/2nfcENs
January 25, 2018
Rose
Healthy Living, WebMD Health
No comments
from WebMD Health http://ift.tt/2nfcENs
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment